MDPLF
Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. It is developing SkinJect with an indication for basal cell carcinoma. The company is headquartered in Toronto, Canada.
Market Cap & Net Worth: MDPLF (MDPLF)
MDPLF (PINK:MDPLF) has a market capitalization of $29.24 Million ($29.24 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #43391 globally and #13893 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MDPLF's stock price $2.70 by its total outstanding shares 10846800 (10.85 Million).
MDPLF Market Cap History: 2024 to 2024
MDPLF's market capitalization history from 2024 to 2024. Data shows growth from $29.24 Million to $29.24 Million (0.00% CAGR).
MDPLF Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MDPLF's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MDPLF by Market Capitalization
Companies near MDPLF in the global market cap rankings as of March 18, 2026.
Key companies related to MDPLF by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
MDPLF Historical Marketcap From 2024 to 2024
Between 2024 and today, MDPLF's market cap moved from $29.24 Million to $ 29.24 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $29.24 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of MDPLF was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.24 Million USD |
| MoneyControl | $29.24 Million USD |
| MarketWatch | $29.24 Million USD |
| marketcap.company | $29.24 Million USD |
| Reuters | $29.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.